Gout flare prophylaxis during management of chronic gout with febuxostat, a non-purine selective inhibitor of xanthine oxidase.

被引：0
|
作者：
Wortmann, R
Becker, MA
Schumacher, HR
MacDonald, P
Palo, WA
Joseph-Ridge, N
机构：
[1] Univ Oklahoma, Tulsa, OK USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Univ Penn, VAMC, Philadelphia, PA 19104 USA
[4] TAP Pharmaceut Prod Inc, Lake Forest, IL USA
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S335 / S336
页数：2
相关论文
共 49 条
  • [21] Effect of febuxostat, a novel non-purine, selective inhibitor of xanthine oxidase (NP-SIXO), on enzymes in purine and pyrimidine metabolism pathway.
    Lin, Z
    Takano, Y
    Horiuchi, H
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S531 - S531
  • [22] EFFECTS OF XANTHINE OXIDASE INHIBITOR ON CLINICAL MANIFESTATIONS + PURINE METABOLISM IN GOUT
    RUNDLES, RW
    SILBERMAN, HR
    ELION, GB
    HITCHINGS, GH
    ANNALS OF INTERNAL MEDICINE, 1964, 60 (04) : 717 - +
  • [23] Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers
    Becker, MA
    Kisicki, J
    Khosravan, R
    Wu, J
    Mulford, D
    Hunt, B
    MacDonald, P
    Joseph-Ridge, N
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2004, 23 (8-9): : 1111 - 1116
  • [24] A phase 2, long term open-label safety and efficacy study of febuxostat, a novel non-purine, selective inhibitor of xanthine oxidase
    Schumacher, HE
    Wortmann, R
    Becke, MA
    MacDonald, P
    Palo, WA
    Eustace, D
    Streit, J
    Joseph-Ridge, N
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S335 - S335
  • [25] Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in InsAkita diabetic mice
    Itano, Seiji
    Kadoya, Hiroyuki
    Satoh, Minoru
    Nakamura, Takashi
    Murase, Takayo
    Sasaki, Tamaki
    Kanwar, Yashpal S.
    Kashihara, Naoki
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2020, 319 (05) : F765 - F772
  • [26] Placebo-Controlled, Double-Blind Study of the Non-Purine-Selective Xanthine Oxidase Inhibitor Febuxostat (TMX-67) in Patients With Hyperuricemia Including Those With Gout in Japan
    Naoyuki, Kamatani
    Shin, Fujimori
    Toshikazu, Hada
    Tatsuo, Hosoya
    Kenjiro, Kohri
    Toshitaka, Nakamura
    Takanori, Ueda
    Tetsuya, Yamamoto
    Hisashi, Yamanaka
    Yuji, Matsuzawa
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2011, 17 (04) : S19 - S26
  • [27] 3,5,2′,4′-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor
    Niu, Yanfen
    Zhu, Huajie
    Liu, Jia
    Fan, Huafang
    Sun, Ling
    Lu, Wei
    Liu, Xu
    Li, Ling
    CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 189 (03) : 161 - 166
  • [28] Placebo-Controlled Double-Blind Dose-Response Study of the Non-Purine-Selective Xanthine Oxidase Inhibitor Febuxostat (TMX-67) in Patients With Hyperuricemia (Including Gout Patients) in Japan
    Naoyuki, Kamatani
    Shin, Fujimori
    Toshikazu, Hada
    Tatsuo, Hosoya
    Kenjiro, Kohri
    Toshitaka, Nakamura
    Takanori, Ueda
    Tetsuya, Yamamoto
    Hisashi, Yamanaka.
    Yuji, Matsuzawa
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2011, 17 (04) : S35 - S43
  • [29] A novel electrochemical sensor based on gold nanoparticles decorated functionalized carbon nanofibers for selective determination of xanthine oxidase inhibitor febuxostat in plasma of patients with gout
    Ibrahim, Hossieny
    Temerk, Yassien
    SENSORS AND ACTUATORS B-CHEMICAL, 2021, 347
  • [30] Study on the activity of non-purine xanthine oxidase inhibitor by 3D-QSAR modeling and molecular docking
    Li, Peizhen
    Tian, Yueli
    Zhai, Honglin
    Deng, Fangfang
    Xie, Meihong
    Zhang, Xiaoyun
    JOURNAL OF MOLECULAR STRUCTURE, 2013, 1051 : 56 - 65
12345